Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
ConditionBladder Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This study explores and compares health-related quality of life and urinary outcomes in postoperative partial cystectomy and matched radical cystectomy patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Currently living partial cystectomy patients in Mayo Urology's cystectomy registry and patients undergoing radical or partial cystectomy
Matched 2:1 living radical cystectomy to partial cystectomy patients
Either urothelial or non-urothelial histology
Disqualifiers
Partial cystectomy patients that underwent subsequent radical cystectomy
Trial population
Currently living partial cystectomy patients in Mayo Urology's cystectomy registry and patients undergoing radical or partial cystectomy.
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Non-Interventional Study
Other interventionNon-interventional study
Treatment groups
300 Participants
are divided into 2 treatment groupsGroup A: Observational - Radical Cystectomy1 intervention
Group B: Observational - Partial Cystectomy1 intervention
Trial outcomes
Primary outcomes
1
Health-related quality of life - EORTC QLQ-C30
Assessed using the EORTC Core Quality of Life questionnaire (EORTC QLQ-C30), which is designed to measure cancer patients' physical, psychological and social functions. It is a 30-item questionnaire related to symptoms and activities during the past week. Responses are recorded on a scale of 1-4 where 1=not at all, 2=a little, 3=quite a bit, and 4=very much. Scores among partial cystectomy patients will be compared to radical cystectomy patients.
Time frame
Up to 1 year2
Self-reported urinary outcomes
Assessed using the EORTC Quality of Life Questionnaire - Muscle Invasive Bladder Cancer (EORTC QLQ-BLM30), a 30-item questionnaire related to general symptoms experienced during the past week or during the past 4 weeks. Responses are recorded on a scale of 1-4 where 1=not at all, 2=a little, 3=quite a bit, and 4=very much. Scores among partial cystectomy patients will be compared to radical cystectomy patients.
Time frame
Up to 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov